SOPHiA GENETICS S.A. (SOPH) Financials

SOPH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 157.0 million 111.3 million
Dec. 31, 2025 163.5 million 116.3 million
Sept. 30, 2025 163.5 million 102.8 million
June 30, 2025 177.6 million 100.9 million

SOPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -17.1 million ?
Dec. 31, 2025 -9.3 million 3.9 million
Sept. 30, 2025 -8.9 million 4.1 million
June 30, 2025 -10.2 million 4.4 million

SOPH Net Income

No data available :(

SOPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 65.4 million 47.8 million 11.9 million
Dec. 31, 2025 70.3 million 47.7 million 12.6 million
Sept. 30, 2025 81.6 million 47.6 million 15.8 million
June 30, 2025 94.8 million 47.5 million 16.3 million

SOPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 71.1 million
Dec. 31, 2025 68.2 million
Sept. 30, 2025 67.8 million
June 30, 2025 67.3 million

SOPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 878000 9.5 million 22.6 million -
Dec. 31, 2025 348419 8.5 million 24.2 million -
Sept. 30, 2025 106000 9.4 million 22.6 million 8.7 million
June 30, 2025 2.0 million 8.5 million 22.3 million 10.0 million

SOPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 21.7 million 6.9 million
Dec. 31, 2025 21.7 million 7.0 million
Sept. 30, 2025 19.5 million 6.6 million
June 30, 2025 18.3 million 6.1 million

SOPH

Price: $5

52 week price:
2.59
5.70

Earnings Per Share: -1.18 USD

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Country: Switzerland

Volume: 4190

Market Capitalization: 342.6 million

Links: